Structure of limonene synthase, a simple model for terpenoid cyclase catalysis von Hyatt, David C, Youn, Buhyun, Zhao, Yuxin, Santhamma, Bindu, Coates, Robert M, Croteau, Rodney B, Kang, ChulHee

Volltext

Extranuclear Functions of ER Impact Invasive Migration and Metastasis by Breast Cancer Cells von CHAKRAVARTY, Dimple, NAIR, Sujit S, LEE, Francis Y, RAO TEKMAL, Rajeshwar, KUMAR, Rakesh, VADIAMUDI, Ratna K, SANTHAMMA, Bindu, NAIR, Binoj C, LONG WANG, BANDYOPADHYAY, Abhik, AGYIN, Joseph K, BRANN, Darrell, SUN, Lu-Zhe, YEH, I-Tien

Volltext

Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis von Ebrahimi, Behnam, Viswanadhapalli, Suryavathi, Pratap, Uday P., Rahul, Gopalam, Yang, Xue, Pitta Venkata, Prabhakar, Drel, Viktor, Santhamma, Bindu, Konda, Swapna, Li, Xiaonan, Sanchez, Alondra Lee Rodriguez, Yan, Hui, Sareddy, Gangadhara R., Xu, Zhenming, Singh, Brij B., Valente, Philip T., Chen, Yidong, Lai, Zhao, Rao, Manjeet, Kost, Edward R., Curiel, Tyler, Tekmal, Rajeshwar R., Nair, Hareesh B., Vadlamudi, Ratna K.

Volltext

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer von Tang, Weiwei, Ramasamy, Kumaraguruparan, Pillai, Sureshkumar M. A., Santhamma, Bindu, Konda, Swapna, Pitta Venkata, Prabhakar, Blankenship, Logan, Liu, Junhao, Liu, Zexuan, Altwegg, Kristin A., Ebrahimi, Behnam, Pratap, Uday P., Li, Xiaonan, Valente, Philip T., Kost, Edward, Sareddy, Gangadhara R., Vadlamudi, Ratna K., Nair, Hareesh B., Tekmal, Rajeshwar R., Viswanadhapalli, Suryavathi

Volltext

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer von Li, Mengxing, Viswanadhapalli, Suryavathi, Santhamma, Bindu, Pratap, Uday P., Luo, Yiliao, Liu, Junhao, Altwegg, Kristin A., Tang, Weiwei, Liu, Zexuan, Li, Xiaonan, Ebrahimi, Behnam, Yan, Hui, Zou, Yi, Konda, Swapna, Sareddy, Gangadhara R., Xu, Zhenming, Chen, Yidong, Rao, Manjeet K., Brenner, Andrew J., Kaklamani, Virginia G., Tekmal, Rajeshwar R., Ahmed, Gulzar, Raj, Ganesh V., Nickisch, Klaus J., Nair, Hareesh B., Vadlamudi, Ratna K.

Volltext

Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo von Nair, Hareesh B, Santhamma, Bindu, Krishnegowda, Naveen K, Dileep, Kalarikkal V, Nickisch, Klaus J

Volltext

N-Heterocyclic Carbenes: Reagents, Not Just Ligands von Nair, Vijay, Bindu, Santhamma, Sreekumar, Vellalath

Volltext

Hydroquinoid Chromium Complexes Bearing an Acyclic Conjugated Bridge: Chromium-Templated Synthesis, Molecular Structure, and Haptotropic Metal Migration von Hegele, Peter, Santhamma, Bindu, Schnakenburg, Gregor, Fröhlich, Roland, Kataeva, Olga, Nieger, Martin, Kotsis, Konstantinos, Neese, Frank, Dötz, Karl Heinz

Volltext

Synthesis of substituted estradiols by the selective aromatization of A-ring of steroidal 19-nor-Δ-4-3-ketones with phenylselenyl halides/hydrogen peroxide von Santhamma, Bindu, Nickisch, Klaus

Volltext

Abstract LB-208: First-in-class steroidal leukemia inhibitory factor (LIF) inhibitor in targeted cancer therapy von Nair, Hareesh B., Santhamma, Bindu, Viswanadhapa, Surya, Nickisch, Klaus J.

Volltext

Abstract A195: A novel selective estrogen receptor degrader, EC-372, inhibits tumor growth and metastasis of breast cancer cells von Parashar, Deepak, Geethadevi, Anjali, Mishra, Jyotsna, Nair, Bindu, Santhamma, Bindu, Nickisch, Klaus, Chaluvally-Raghavan, Pradeep

Volltext

Abstract P5-10-01: Leukemia inhibitory factor receptor inhibition reduces obesity driven progression of triple negative breast cancer von Viswanadhapalli, Suryavathi, Pratap, Uday P, Ebrahimi, Behnam, Blankenship, Logan, Joshi, Jaitri, Liu, Zexuan, Altwegg, Kristin A, Li, Xiaonan, Sareddy, Gangadhara R, Santhamma, Bindu, Konda, Swapna, Rao, Manjeet, Kost, Edward, Tekmal, Rajeshwar R, Nair, Hareesh B, Vadlamudi, Ratna K

Volltext

EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer von Viswanadhapalli, Suryavathi, Luo, Yiliao, Sareddy, Gangadhara R, Santhamma, Bindu, Zhou, Mei, Li, Mengxing, Ma, Shihong, Sonavane, Rajni, Pratap, Uday P, Altwegg, Kristin A, Li, Xiaonan, Chang, Annabel, Chávez-Riveros, Alejandra, Dileep, Kalarickal V, Zhang, Kam Y J, Pan, Xinlei, Murali, Ramachandran, Bajda, Marek, Raj, Ganesh V, Brenner, Andrew J, Manthati, Vijaya, Rao, Manjeet K, Tekmal, Rajeshwar R, Nair, Hareesh B, Nickisch, Klaus J, Vadlamudi, Ratna K

Volltext

A new approach towards the synthesis of drospirenone and steroidal spirolactones von Santhamma, Bindu, Acosta, Kirk, Chavez-Riveros, Alejandra, Nickisch, Klaus

Volltext

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer von Altwegg, Kristin A, Viswanadhapalli, Suryavathi, Mann, Monica, Chakravarty, Dimple, Krishnan, Samaya, Liu, Zexuan, Liu, Junhao, Pratap, Uday P, Ebrahimi, Behnam, Sanchez, John R, Li, Xiaonan, Ma, Shihong, Park, Ben H, Santhamma, Bindu, Chen, Yidong, Lai, Zhao, Raj, Ganesh V, Yuan, Yaxia, Zhou, Daohong, Sareddy, Gangadhara R, Tekmal, Rajeshwar R, McHardy, Stan, Huang, Tim H-M, Rao, Manjeet K, Vankayalapati, Hariprasad, Vadlamudi, Ratna K

Volltext

The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling von Spencer, Nicole, Rodriguez Sanchez, Alondra Lee, Gopalam, Rahul, Subbarayalu, Panneerdoss, Medina, Daisy M, Yang, Xue, Ramirez, Paulina, Randolph, Lois, Aller, Emily Jean, Santhamma, Bindu, Rao, Manjeet K, Tekmal, Rajeshwar Rao, Nair, Hareesh B, Kost, Edward R, Vadlamudi, Ratna K, Viswanadhapalli, Suryavathi

Volltext

Abstract P3-05-08: Effect of a novel selective progesterone receptor modulator EC312 for menopausal hormone therapy (MHT) in comparison with Bazedoxifene in vitro von Nair, Hareesh B, Santhamma, Bindu, Elger, Walter, Nickisch, Klaus J

Volltext

Abstract 4316: Targeting LIFR overcomes HDAC inhibitor resistance in ovarian cancer von Li, Mengxing, Viswanadhapalli, Suryavathi, Sareddy, Gangadhara Reddy, Santhamma, Bindu, Yan, Hui, Xu, Zhenming, Kost, Edward, Tekmal, Rajeshwar Rao, Nair, Hareesh B., Nickisch, Klaus J., Vadlamudi, Ratna K.

Volltext

Abstract P3-11-08: Targeting LIFR enhances the activity of HDAC inhibitors for the treatment of triple negative breast cancer von Viswanadhapalli, Suryavathi, Li, Mengxing, Santhamma, Bindu, Pratap, Uday P, Luo, Yiliao, Liu, Junhao, Altwegg, Kristin A, Li, Xiaonan, Yan, Hui, Xu, Zhenming, Brenner, Andrew, Sareddy, Gangadhara R, Tekmal, Rajeshwar R, Nair, Hareesh B, Nickisch, Klaus J, Vadlamudi, Ratna K

Volltext

Abstract 1253: Therapeutic targeting of endometrial cancer with novel LIFR inhibitor EC359 von Tang, Weiwei, Ramasamy, Kumaraguruparan, Pillai, Sureshkumar M., Santhamma, Bindu, Konda, Swapna, Vekata, Prabhakar P., Blankenship, Logan, Liu, Junhao, Liu, Zexuan, Altwegg, Kristin A., Ebrahimi, Behnam, Pratap, Uday P., Li, Xiaonan, Kost, Edward, Sareddy, Gangadhara R., Vadlamudi, Ratna K., Nair, Hareesh B., Tekmal, Rajeshwar R., Viswanadhapalli, Suryavathi

Volltext